For those of you in the i2b2 community, this piece in Science Translational Medicine may be obvious. I am pretty sure it's not an obvious conclusion to all (particularly some of the vendors) so you might want to read it for reference.
For those of you in the i2b2 community, this piece in Science Translational Medicine may be obvious. I am pretty sure it's not an obvious conclusion to all (particularly some of the vendors) so you might want to read it for reference.
